Forte Biosciences, Inc. (FBRX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 65.11M | 80.59M | 95.41M | 107.62M | 47.16M | 61.35M | 17.67M | 25.71M | 31.5M | 38.33M | 47.1M | 30.75M |
| Cash & Short-Term Investments | 58.22M | 76.96M | 93.41M | 106.14M | 45.86M | 58.37M | 16.36M | 24.5M | 30.44M | 37.13M | 46.19M | 30.43M |
| Cash Only | 58.22M | 76.96M | 93.41M | 106.14M | 45.86M | 22.24M | 16.36M | 24.5M | 10.63M | 11.96M | 21.14M | 20.44M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 36.12M | 0 | 0 | 19.81M | 25.16M | 25.04M | 9.99M |
| Accounts Receivable | 0 | 817K | 527K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 6.89M | 2.81M | 1.47M | 588K | 449K | 336K | 274K | 313K | 233K | 165K | 94K | 129K |
| Total Non-Current Assets | 2.11M | 2.19M | 1.68M | 167K | 301K | 215K | 278K | 367K | 515K | 653K | 777K | 437K |
| Property, Plant & Equipment | 110K | 129K | 148K | 110K | 125K | 77K | 86K | 96K | 106K | 109K | 98K | 30K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 2M | 2.06M | 1.53M | 57K | 176K | 138K | 192K | 271K | 409K | 544K | 679K | 407K |
| Total Assets | 67.22M | 82.78M | 97.09M | 107.78M | 47.46M | 61.56M | 17.95M | 26.08M | 32.02M | 38.98M | 47.88M | 31.18M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 41.64% | 34.47% | 441.01% | 313.31% | 48.23% | 57.93% | -62.52% | -16.37% | -12.78% | -7.18% | 6.1% | -21.49% |
| Total Current Liabilities | 23.65M | 20.75M | 12.99M | 9.17M | 9.03M | 9.08M | 8.58M | 9.12M | 3.33M | 3.67M | 7.47M | 6.3M |
| Accounts Payable | 13.08M | 9.99M | 5.49M | 5.3M | 5.02M | 4.88M | 5.16M | 5.28M | 1.69M | 1.42M | 5.35M | 3.01M |
| Days Payables Outstanding | 54.65K | -15.82K | 29.2K | 31.32K | 34.28K | 46.17K | 48K | 31.67K | 15.72K | 51.96K | 128.19K | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 10.56M | 10.76M | 7.5M | 934K | 1.25M | 1.55M | 1.22M | 1.03M | 813K | 947K | 0 | 0 |
| Current Ratio | 2.75x | 3.88x | 7.34x | 11.74x | 5.22x | 6.76x | 2.06x | 2.82x | 9.45x | 10.45x | 6.30x | 4.88x |
| Quick Ratio | 2.75x | 3.88x | 7.34x | 11.74x | 5.22x | 6.76x | 2.06x | 2.82x | 9.45x | 10.45x | 6.30x | 4.88x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.48M | 1.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.48M | 1.04M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 25.12M | 21.79M | 12.99M | 9.17M | 9.03M | 9.08M | 8.58M | 9.12M | 3.33M | 3.67M | 7.47M | 6.3M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -58.22M | -76.96M | -93.41M | -106.14M | -45.86M | -22.24M | -16.36M | -24.5M | -10.63M | -11.96M | -21.14M | -20.44M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | -68.59x | - | - |
| Total Equity | 42.1M | 60.99M | 84.1M | 98.61M | 38.43M | 52.48M | 9.37M | 16.96M | 28.68M | 35.31M | 40.41M | 24.88M |
| Equity Growth % | 9.56% | 16.22% | 797.9% | 481.41% | 33.96% | 48.61% | -76.82% | -31.84% | -12.94% | -9.03% | -5.67% | -34.87% |
| Book Value per Share | 0.24 | 0.41 | 4.73 | 8.40 | 3.37 | 8.21 | 5.07 | 9.19 | 18.46 | 24.30 | 26.68 | 29.56 |
| Total Shareholders' Equity | 42.1M | 60.99M | 84.1M | 98.61M | 38.43M | 52.48M | 9.37M | 16.96M | 28.68M | 35.31M | 40.41M | 24.88M |
| Common Stock | 14K | 13K | 13K | 12K | 6K | 6K | 1K | 36K | 36K | 36K | 36K | 21K |
| Retained Earnings | -245.51M | -223.37M | -198.59M | -180.9M | -169.65M | -154M | -146.84M | -138.45M | -125.94M | -118.52M | -112.65M | -102.69M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -4K | 3K | -6K | 0 | 0 | 11K | 1K | -7K | -2K | 4K | -5K | 1K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |